SCHEMBL8890735

SCHEMBL8890735

CN(C)c1ccc2nc(Nc3ccccc3)nc(Nc3cccc(Cl)c3)c2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.63
NPY5R Q15761 5/20 0.53
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
KDM4E B2RXH2 1/20 0.51
CYP1A2 P05177 1/20 0.51
POLB P06746 1/20 0.51
HSP90AA1 P07900 1/20 0.51
CYP3A4 P08684 1/20 0.51
MAPT P10636 1/20 0.51
CYP2C9 P11712 1/20 0.51
HPGD P15428 1/20 0.51
MAPK1 P28482 1/20 0.51
CYP2C19 P33261 1/20 0.51
HSD17B10 Q99714 1/20 0.51
ACP1 P24666 1/20 0.49
PDE5A O76074 2/20 0.49
KDM1A O60341 2/20 0.49
ABCG2 Q9UNQ0 2/20 0.49
SOS1 Q07889 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8888779 0.99 EGFR (0.62) EGFRNPY5RMEN1KMT2AKDM4E
SCHEMBL8893267 0.90 NPY5R (0.60) EGFRNPY5RKDM1ANPC1PKM
Hydrochloric Acid SCHEMBL8909035 0.89 NPY5R (0.59) EGFRNPY5RKDM1ANPC1PKM
SCHEMBL8889656 0.87 EGFR (0.54) EGFRMEN1KMT2AKDM4ECYP1A2
SCHEMBL2590759 0.82 NPY5R (0.76) EGFRNPY5RMEN1KMT2AKDM4E
SCHEMBL8901496 0.82 NPY5R (0.68) NPY5RKDM1AABCG2NPC1PKM
Hydrochloric Acid SCHEMBL8913197 0.81 NPY5R (0.67) NPY5RPOLBKDM1AABCG2NPC1
SCHEMBL2587936 0.79 NPY5R (0.84) EGFRNPY5RMEN1KMT2AKDM4E
SCHEMBL2592190 0.79 NPY5R (0.78) EGFRNPY5RMEN1KMT2AKDM4E
SCHEMBL8908702 0.77 NPY5R (0.74) NPY5RKDM1ANPC1PKMRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997020822-A1 QUINAZOLIN-2,4-DIAZIRINES AS NPY RECEPTOR ANTAGONIST NOVARTIS AG (CH) 1997-06-12 WO claimed